Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,268,820
+$371,400 QoQ
Shares Held
16,964
-5.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,418
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILTON INVESTMENT CO INC. holds $21,642,442 across 10 Drug Manufacturers - General names. ABBV ranks #3 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,720 | $6,860,740 | |
| 2 | JNJ |
Johnson & Johnson
|
20,745 | $5,268,607 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
16,964 | $4,268,820 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,953 | $1,792,960 | |
| 5 | AMGN |
Amgen Inc
|
3,302 | $1,195,720 | |
| 6 | AZN |
Astrazeneca PLC
|
5,268 | $998,918 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,562 | $435,722 | |
| 8 | NVS |
Novartis AG
|
2,250 | $352,620 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,268,820 | 16,964 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,897,420 | 17,920 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,765,515 | 16,480 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,622,211 | 15,644 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,703,369 | 14,564 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,857,014 | 13,636 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,589,622 | 14,573 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,877,876 | 14,573 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,499,560 | 14,573 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,257,129 | 12,395 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,888,309 | 12,185 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,832,841 | 12,296 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,378,018 | 10,228 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,553,379 | 9,747 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,575,212 | 9,747 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,308,144 | 9,747 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,381,350 | 9,019 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $1,164,436 | 7,183 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $972,578 | 7,183 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $712,697 | 6,607 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $749,056 | 6,650 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $798,122 | 7,375 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,039,033 | 9,697 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $913,563 | 10,430 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $837,769 | 8,533 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||